HIGHLIGHTS
- who: Levin Häni and collaborators from the Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland have published the research: Quantitative Analysis of the MGMT Methylation Status of Glioblastomas in Light of the 2021 WHO Classification, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of /2022/
- what: The aim of the study was to determine a methylation threshold for better survival among patients with glioblastomas. The study data are available and will be shared upon reasonable request from other . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.